Omega-3 fatty acid therapy dose-dependently and significantly decreased triglycerides and improved flow-mediated dilation, however, did not significantly improve insulin sensitivity in patients with hypertriglyceridemia

International Journal of Cardiology

Volumn 176, Issue 3, 2014, Pages 696-702

  Oh, Pyung Chun ^a,b   Koh, Kwang Kon ^a,b   Sakuma, Ichiro ^c   Lim, Soo ^d   Lee, Yonghee ^e   Lee, Seungik ^a,b   Lee, Kyounghoon ^a,b   Han, Seung Hwan ^a,b   Shin, Eak Kyun ^a,b  

^a Gachon University College of Medicine   (South Korea)

^b Gachon Cardiovascular Research Institute   (South Korea)

^c Hokko Memorial Clinic   (Japan)

^d Seoul National University Bundang Hospital   (South Korea)

^e University of Seoul   (South Korea)

Author keywords

Atherosclerosis; Hypertriglyceridemia; Insulin resistance; Omega 3 fatty acids

Indexed keywords

OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

BLOOD; BLOOD FLOW VELOCITY; CONTROLLED STUDY; DIABETES MELLITUS, TYPE 2; DOSE RESPONSE; DRUG EFFECTS; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MALE; MIDDLE AGED; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; VASODILATATION;

BLOOD FLOW VELOCITY; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MALE; MIDDLE AGED; SINGLE-BLIND METHOD; TREATMENT OUTCOME; TRIGLYCERIDES; VASODILATION;

EID: 84908256265     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.07.075     Document Type: Article

References (55)

1. Dietary supplementation with n - 3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial: Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico Lancet 354 1999 447 455
2. R. Marchioli, F. Barzi, and E. Bomba GISSI-Prevenzione investigators. Early protection against sudden death by n - 3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione Circulation 105 2002 1897 1903
3. M.T. Streppel, M.C. Ocke, H.C. Boshuizen, F.J. Kok, and D. Kromhout Long-term fish consumption and n - 3 fatty acid intake in relation to (sudden) coronary heart disease death: the Zutphen study Eur Heart J 29 2008 2024 2030
4. H.E. Bays, A.P. Tighe, R. Sadovsky, and M.H. Davidson Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications Expert Rev Cardiovasc Ther 6 2008 391 409
5. T.A. Mori, G.F. Watts, V. Burke, E. Hilme, I.B. Puddey, and L.J. Beilin Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men Circulation 102 2000 1264 1269
6. A. Stirban, S. Nandrean, and C. Gotting Effects of n - 3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus Am J Clin Nutr 91 2010 808 813
7. S. Kotwal, M. Jun, D. Sullivan, V. Perkovic, and B. Neal Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis Circ Cardiovasc Qual Outcomes 5 2012 808 818
8. J. Kim, M. Montagnani, K.K. Koh, and M.J. Quon Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms Circulation 113 2006 1888 1904
9. S.H. Han, M.J. Quon, and K.K. Koh Reciprocal relationships between abnormal metabolic parameters and endothelial dysfunction Curr Opin Lipidol 18 2007 58 65
10. S.H. Jee, and J. Jo Linkage of epidemiologic evidence with the clinical aspects of metabolic syndrome Korean Circ J 42 2012 371 378
11. S.H. Han, M.J. Quon, J.A. Kim, and K.K. Koh Adiponectin and cardiovascular disease: response to therapeutic interventions J Am Coll Cardiol 49 2007 531 538
12. S. Lim, M.J. Quon, and K.K. Koh Modulation of adiponectin as a potential therapeutic strategy Atherosclerosis 233 2014 721 728
13. M.J. Holness, N.D. Smith, G.K. Greenwood, and M.C. Sugden Acute omega-3 fatty acid enrichment selectively reverses high-saturated fat feeding-induced insulin hypersecretion but does not improve peripheral insulin resistance Diabetes 53 2004 S166 S171 [Suppl.]
14. G. Svegliati-Baroni, C. Candelaresi, and S. Saccomanno A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor alpha and n - 3 polyunsaturated fatty acid treatment on liver injury Am J Pathol 169 2006 846 860
15. M. Kaushik, D. Mozaffarian, D. Spiegelman, J.E. Manson, W.C. Willett, and F.B. Hu Long-chain omega-3 fatty acids, fish intake, and the risk of type 2 diabetes mellitus Am J Clin Nutr 90 2009 613 620
16. L. Djousse, J.M. Gaziano, J.E. Buring, and I.M. Lee Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes Am J Clin Nutr 93 2011 143 150
17. K.K. Koh, M.J. Quon, and K.C. Shin Significant differential effects of omega-3 fatty acids and fenofibrate in patients with hypertriglyceridemia Atherosclerosis 220 2012 537 544
18. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
19. K.K. Koh, M.J. Quon, and S.H. Han Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients Circulation 110 2004 3687 3692
20. K.K. Koh, S.H. Han, M.J. Quon, J.Y. Ahn, and E.K. Shin Beneficial effects of fenofibrate to improve endothelial dysfunction and raise adiponectin levels in patients with primary hypertriglyceridemia Diabetes Care 28 2005 1419 1424
21. K.K. Koh, M.J. Quon, S.H. Han, Y. Lee, S.J. Kim, and E.K. Shin Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients J Am Coll Cardiol 55 2010 1209 1216
22. K.K. Koh, M.J. Quon, and S. Lim Effects of fenofibrate therapy on circulating adipocytokines in patients with primary hypertriglyceridemia Atherosclerosis 214 2011 144 147
23. K.K. Koh, M.J. Quon, and I. Sakuma Differential metabolic effects of rosuvastatin and pravastatin in hypercholesterolemic patients Int J Cardiol 166 2013 509 515
24. K.K. Koh, S. Lim, and H. Choi Combination pravastatin and valsartan treatment has additive beneficial effects to simultaneously improve both metabolic and cardiovascular phenotypes beyond that of monotherapy with either drug in patients with primary hypercholesterolemia Diabetes 62 2013 3547 3552
25. A. Katz, S.S. Nambi, and K. Mather Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans J Clin Endocrinol Metab 85 2000 2402 2410
26. J. Goodfellow, M.F. Bellamy, M.W. Ramsey, C.J. Jones, and M.J. Lewis Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia J Am Coll Cardiol 35 2000 265 270
27. M.M. Engler, M.B. Engler, and M. Malloy Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY study Int J Clin Pharmacol Ther 42 2004 672 679
28. S. Rizza, M. Tesauro, and C. Cardillo Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes Atherosclerosis 206 2009 569 574
29. D. Lopez, M. Moller, and A. Denicola Long-chain n - 3 polyunsaturated fatty acid from fish oil modulates aortic nitric oxide and tocopherol status in the rat Br J Nutr 100 2008 767 775
30. Y. Okuda, K. Kawashima, and T. Sawada Eicosapentaenoic acid enhances nitric oxide production by cultured human endothelial cells Biochem Biophys Res Commun 232 1997 487 491
31. M. Omura, S. Kobayashi, and Y. Mizukami Eicosapentaenoic acid (EPA) induces Ca(2 +)-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxation FEBS Lett 487 2001 361 366
32. R. De Caterina, M.I. Cybulsky, S.K. Clinton, M.A. Gimbrone Jr., and P. Libby The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells Arterioscler Thromb 14 1994 1829 1836
33. S. Lim, Y.M. Park, I. Sakuma, and K.K. Koh How to control residual cardiovascular risk despite statin treatment: focusing on HDL-cholesterol Int J Cardiol 166 2013 8 14
34. Emerging Risk Factors Collaboration E. Di Angelantonio, and N. Sarwar Major lipids, apolipoproteins, and risk of vascular disease JAMA 302 2009 1993 2000
35. K. Ahmed, M.H. Jeong, and R. Chakraborty Clinical impact of non-high density lipoprotein-cholesterol and apolipoprotein B on clinical outcomes in metabolic syndrome patients with acute myocardial infarction undergoing percutaneous coronary intervention Korean Circ J 42 2012 319328
36. R.H. Eckel The fish oil story remains fish Circulation 122 2010 2110 2112
37. H. Chen, M. Montagnani, T. Funahashi, I. Shimomura, and M.J. Quon Adiponectin stimulates production of nitric oxide in vascular endothelial cells J Biol Chem 278 2003 45021 45026
38. J. Kim, K.K. Koh, and M.J. Quon The union of vascular and metabolic actions of insulin in sickness and in health Arterioscler Thromb Vasc Biol 25 2005 889 891
39. K.J. Mather, A.E. Hunt, and H.O. Steinberg Repeatability characteristics of simple indices of insulin resistance: implications for research applications J Clin Endocrinol Metab 86 2001 5457 5464
40. A.J. Hanley, K. Williams, and C. Gonzalez Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study Diabetes 52 2003 463 469
41. A.S. Rossi, Y.B. Lombardo, and J.M. Lacorte Dietary fish oil positively regulates plasma leptin and adiponectin levels in sucrose-fed, insulin-resistant rats Am J Physiol Regul Integr Comp Physiol 289 2005 R486 R494
42. S. Neschen, K. Morino, and J.C. Rossbacher Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-gamma-dependent mechanism in mice Diabetes 55 2006 924 928
43. M.K. Duda, K.M. O'Shea, and B. Lei Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload Cardiovasc Res 76 2007 303 310
44. A.A. Bueno, L.M. Oyama, and C. de Oliveira Effects of different fatty acids and dietary lipids on adiponectin gene expression in 3T3-L1 cells and C57BL/6J mice adipose tissue Pflugers Arch 455 2008 701 709
45. D.Y. Oh, S. Talukdar, and E.J. Bae GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects Cell 142 2010 687 698
46. S. Lorente-Cebrian, P. Perez-Matute, J.A. Martinez, A. Marti, and M.J. Moreno-Aliaga Effects of eicosapentaenoic acid (EPA) on adiponectin gene expression and secretion in primary cultured rat adipocytes J Physiol Biochem 62 2006 61 69
47. M. Kratz, M.M. Swarbrick, H.S. Callahan, C.C. Matthys, P.J. Havel, and D.S. Weigle Effect of dietary n - 3 polyunsaturated fatty acids on plasma total and high-molecular-weight adiponectin concentrations in overweight to moderately obese men and women Am J Clin Nutr 87 2008 347 353
48. D.S. Kelley, Y. Adkins, L.R. Woodhouse, A. Swislocki, B.E. Mackey, and D. Siegel Docosahexaenoic acid supplementation improved lipocentric but not glucocentric markers of insulin sensitivity in hypertriglyceridemic men Metab Syndr Relat Disord 10 2012 32 38
49. A.O. Akinkuolie, J.S. Ngwa, J.B. Meigs, and L. Djousse Omega-3 polyunsaturated fatty acid and insulin sensitivity: a meta-analysis of randomized controlled trials Clin Nutr 30 2011 702 707
50. V.M. Montori, A. Farmer, P.C. Wollan, and S.F. Dinneen Fish oil supplementation in type 2 diabetes: a quantitative systematic review Diabetes Care 23 2000 1407 1415
51. J. Hartweg, R. Perera, V. Montori, S. Dinneen, H.A. Neil, and A. Farmer Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus Cochrane Database Syst Rev 2008 CD003205
52. L. Tavazzi, A.P. Maggioni, and R. Marchioli Gissi-HF investigators. Effect of n - 3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial Lancet 372 2008 1223 1230
53. M. Yokoyama, H. Origasa, and M. Matsuzaki Japan EPA lipid intervention study (JELIS) investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis Lancet 369 2007 1090 1098
54. B. Rauch, R. Schiele, and S. Schneider OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline adjusted therapy after myocardial infarction Circulation 122 2010 2152 2159
55. D. Kromhout, E. Giltay, and J.M. Geleijnse Alpha omega trial group. n - 3 fatty acids and cardiovascular events after myocardial infarction N Engl J Med 363 2010 2015 2026